Patents by Inventor Daniel Drachman

Daniel Drachman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Targeting antigen-specific T cells for specific immunotherapy of autoimmune disease
    Publication number: 20050163762
    Abstract: Antigen-specific T cells are stimulated to proliferate by activation with properly presented antigen. Targeting a detrimental product to only those cells which are stimulated to proliferate in response to the antigen presentation permits the selective and highly efficient ablation of a key component of the disease symptomology of myasthenia gravis.
    Type: Application
    Filed: June 21, 2004
    Publication date: July 28, 2005
    Applicant: The Johns Hopkins University
    Inventor: Daniel Drachman
  • Fas ligand expressing hematopoietic cells for transplantation
    Publication number: 20040131599
    Abstract: The invention provides methods and compositions utilizing FasL armed donor graft cells to reduce or eliminate host allogeneic or xenogeneic graft rejection, and FasL armed host cells to reduce or eliminate graft versus host disease.
    Type: Application
    Filed: February 25, 2004
    Publication date: July 8, 2004
    Inventors: Curt I Civin, Daniel Drachman, Katherine Whartenby, Drew M Pardoll